| 000 | 01744 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515100148.0 | ||
| 264 | 0 | _c20080116 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1421-9794 | ||
| 024 | 7 |
_a10.1159/000112419 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWestfall, Suzanne D | |
| 245 | 0 | 0 |
_aRole of triptolide as an adjunct chemotherapy for ovarian cancer. _h[electronic resource] |
| 260 |
_bChemotherapy _c2008 |
||
| 300 |
_a67-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aChromones _xadministration & dosage |
| 650 | 0 | 4 |
_aDiterpenes _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aEpoxy Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aMorpholines _xadministration & dosage |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhenanthrenes _xadministration & dosage |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aTripterygium _xchemistry |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aNilsson, Eric E | |
| 700 | 1 | _aSkinner, Michael K | |
| 773 | 0 |
_tChemotherapy _gvol. 54 _gno. 1 _gp. 67-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000112419 _zAvailable from publisher's website |
| 999 |
_c17587058 _d17587058 |
||